Esther Rajavelu
Stock Analyst at UBS
(0.67)
# 3,819
Out of 4,854 analysts
28
Total ratings
43.75%
Success rate
-23.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Rajavelu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $331 → $349 | $300.83 | +16.01% | 6 | May 2, 2025 | |
| APLT Applied Therapeutics | Downgrades: Neutral | $13 → $2 | $0.37 | +441.71% | 3 | Dec 2, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $14.70 | +117.69% | 2 | Apr 9, 2024 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | $73 | $37.17 | +96.42% | 1 | Aug 19, 2021 | |
| BHVN Biohaven | Downgrades: Neutral | $108 → $109 | $17.03 | +540.05% | 6 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | $35 | $11.14 | +214.18% | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $33 → $38 | $35.29 | +6.26% | 3 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $174 → $228 | $111.13 | +105.17% | 1 | Mar 1, 2021 | |
| EYEN Eyenovia | Downgrades: Perform | n/a | $4.88 | - | 2 | Feb 3, 2020 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $16.81 | - | 1 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $13 | $21.58 | -39.76% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.25 | +700.00% | 1 | Jul 21, 2017 |
Alnylam Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $331 → $349
Current: $300.83
Upside: +16.01%
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13 → $2
Current: $0.37
Upside: +441.71%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $14.70
Upside: +117.69%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $37.17
Upside: +96.42%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108 → $109
Current: $17.03
Upside: +540.05%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $11.14
Upside: +214.18%
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: $33 → $38
Current: $35.29
Upside: +6.26%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174 → $228
Current: $111.13
Upside: +105.17%
Eyenovia
Feb 3, 2020
Downgrades: Perform
Price Target: n/a
Current: $4.88
Upside: -
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $16.81
Upside: -
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $21.58
Upside: -39.76%
Jul 21, 2017
Initiates: Buy
Price Target: $10
Current: $1.25
Upside: +700.00%